Caricamento...
Kininase 1 As a Preclinical Therapeutic Target for Kinin B(1) Receptor in Insulin Resistance
Kinin B1 receptor (B1R) contributes to insulin resistance, an early event in type 2 diabetes, through the upregulation and activation of the inducible form of nitric oxide synthase (iNOS), pro-inflammatory cytokines and the oxidative stress. This study addresses the hypothesis that inhibition of kin...
Salvato in:
| Pubblicato in: | Front Pharmacol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5539221/ https://ncbi.nlm.nih.gov/pubmed/28824433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00509 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|